Segall Bryant & Hamill LLC Takes Position in Ardent Health Partners, LLC (NYSE:ARDT)

Segall Bryant & Hamill LLC purchased a new stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 262,207 shares of the company's stock, valued at approximately $4,478,000. Segall Bryant & Hamill LLC owned approximately 0.18% of Ardent Health Partners as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ARDT. US Bancorp DE bought a new position in shares of Ardent Health Partners in the fourth quarter valued at $31,000. Bank of New York Mellon Corp grew its position in shares of Ardent Health Partners by 8.2% in the 4th quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock valued at $438,000 after acquiring an additional 1,941 shares during the period. R Squared Ltd bought a new position in shares of Ardent Health Partners in the 4th quarter valued at about $37,000. BNP Paribas Financial Markets acquired a new position in shares of Ardent Health Partners during the 3rd quarter worth about $42,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners in the 4th quarter valued at about $48,000.

Analyst Ratings Changes

ARDT has been the subject of a number of research analyst reports. Stephens reiterated an "overweight" rating and set a $22.00 price target on shares of Ardent Health Partners in a report on Tuesday. Morgan Stanley reduced their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Truist Financial dropped their price target on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada reduced their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $21.18.

Remove Ads

Ardent Health Partners Price Performance

Shares of ARDT stock traded down $0.83 on Tuesday, hitting $12.92. The company's stock had a trading volume of 621,206 shares, compared to its average volume of 407,208. Ardent Health Partners, LLC has a fifty-two week low of $12.39 and a fifty-two week high of $20.72. The stock's 50 day moving average is $14.38 and its 200-day moving average is $16.15. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. As a group, sell-side analysts forecast that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Ardent Health Partners Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.